Corporate presentation Index: Slide Number Background-2 Core - - PowerPoint PPT Presentation

Corporate presentation

Index: Slide Number Background-2 Core Service Capabilities-3 Inside our Labs-4 Our Team-5 Valuation-6 Contact Information-7

Background

Incorporated as Protealysis Re-organization and rename to BioServUK Relocated to State-of-Art facilities at The Innovation Centre Protein Ark acquired BioServUK

May 2003 Dec 2008 Feb 2013 Mar 2017

A specialist CRO/CMO company with expertise in the production and processing of bio-molecules, primarily antibodies. Using state of the art technology and working under an ISO 9001 quality system, we provide products to biotech, pharma, IVD manufacturers and research institutes. Limited competition. Primary manufacturer positioned to offer de novo Ab production and bulk manufacturing. BioservUK and its key personnel have a strong, established reputation in UK.

2

• Custom de novo monoclonal and polyclonal antibody production with bespoke target

screening.

• Production of bulk mAb from hybridomas and other proteins expressed in mammalian

culture, e.g. CHO, HEK 293, NSO cells.

• Extensive experience in cell line recovery and growth optimization.
• Adaptation to protein free medium (ADCF; Free of Animal Derived Components) –

regulatory compliant, increased yield by up to 30%.

• Routine Purification: Protein A/G chromatography; Immuno-affinity chromatography;

IMAC

• 100% owned Highly validated ELITE Antibodies (catalogue antibodies) focused on

Hormonal Control, Fertility and related Cancers.

10 mg – 100g

Typical purified mAb quantity of customer

• rders (typical 20mg/L

production)

200g

Maximum mAb capacity per annum

4,000L

Maximum cell culture volume per annum

200L

Maximum cell culture volume in a single batch

20L

Wave bag batch capacity

Core Service Capabilities

3

• 4 x large scale

roller incubators

• 3 x high

capacity centrifuges

• 7 x CO2

incubators

• 1 x wave bag

(20L)

• 4 x laminar

flow hoods

• 1 x high

volume tangential cross flow rig

• 3 x -80°C

freezers

• 2 x high capacity

liquid nitrogen dewars

• 4 x purification

systems

• 4 x shaker

incubators

• 2 x gel doc

systems

• 5 x high power

Leica microscopes

Inside Our Labs

4

5

Dr Mike Brownleader CEO/Sales Director Dr Simon Smith Business Development (Founder) Dr Andy Wright Facility Manager Caroline Daye Cell Culture Ian Philips DSP/Kits/QC (ISO 9001:2015) Dr Simon Tanley Kits/Bacteria Expression/DSP Dr Tom Lovewell Kits/Mammalian Expression/DSP Alex Fridgant Marketing Manager George Alexander Accounts & Book-keeper

Our Team

Realise the market value from IVD customers for whom validation is ongoing

6

Vision Long-term Objectives Strategy

Business Vision and Valuation

Expand our catalogue of 100%

• wned monoclonal antibodies for

the research and IVD markets Target early phase Drug Discovery Provide the IVD and research markets with high-quality antibodies and custom services to support advances in clinical diagnostics and improve healthcare Become a one-stop shop for life science customers by working synergistically with Protein Ark in

• rder to provide a gene sequence to purified protein, scale up capability

Expand role as CMO/CRO by bolting on new services and products to existing customers worldwide and lead generation for new, emerging and under-developed markets

BioServUK Ltd The Innovation Center 217 Portobello S1 4DP Sheffield, UK T: +44 (0)114 224 2235 E: info@bioservuk.com W: www.bioservuk.com

7

Contact Information

Mike Brownleader – CEO and Sales Director T: +44 (0) 7917 806 666 E: mike@bioservuk.com Andy Wright – Facility Manager T: +44 (0) 7949 854 993 E: andy.wright@bioservuk.com